PETVIVO HOLDINGS, INC. Financials PetVivo Holdings, Inc.
Equities
PETV
US7168174081
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8197 USD | +2.46% |
|
+11.52% | -22.67% |
| Apr. 11 | PetVivo Holdings, Inc.(OTCPK:PETV) dropped from S&P TMI Index | CI |
| Apr. 10 | PetVivo Holdings, Inc. announced that it has received $0.3 million in funding from A.L. Sarroff Management, LLC | CI |
Valuation
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Capitalization 1 | 71.35 | 19.94 | 29.8 | 13.75 | - |
| Enterprise Value (EV) 1 | 71.35 | 19.94 | 29.8 | 13.75 | 13.75 |
| P/E ratio | -18.4 x | -3.58 x | -3.24 x | -0.85 x | -1.3 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | - | 173 x | 32.5 x | 5.17 x | 1.54 x |
| EV / Revenue | - | 173 x | 32.5 x | 5.17 x | 1.54 x |
| EV / EBITDA | - | - | - | - | - |
| EV / FCF | - | - | - | - | - |
| FCF Yield | - | - | - | - | - |
| Price to Book | - | - | - | - | - |
| Nbr of stocks (in thousands) | 6,796 | 9,775 | 10,838 | 16,770 | - |
| Reference price 2 | 10.50 | 2.040 | 2.750 | 0.8197 | 0.8197 |
| Announcement Date | 6/29/21 | 6/24/22 | 6/29/23 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: März | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net sales 1 | - | 0.1156 | 0.9172 | 2.66 | 8.9 |
| EBITDA | - | - | - | - | - |
| EBIT 1 | - | -5.057 | -8.733 | -12.12 | - |
| Operating Margin | - | -4,374.54% | -952.23% | -455.67% | - |
| Earnings before Tax (EBT) 1 | - | -5.015 | -8.718 | -12.45 | -9.8 |
| Net income 1 | -3.523 | -5.015 | -8.718 | -12.45 | -9.8 |
| Net margin | - | -4,338.61% | -950.5% | -468.19% | -110.11% |
| EPS 2 | -0.5700 | -0.5700 | -0.8500 | -0.9700 | -0.6300 |
| Free Cash Flow | - | - | - | - | - |
| FCF margin | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 6/29/21 | 6/24/22 | 6/29/23 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 0.00498 | 0.051 | 0.0555 | 0.0582 | 0.2233 | - | 0.1256 | - | 0.35 |
| EBITDA | - | - | - | - | - | - | - | - | - |
| EBIT | -1.103 | -1.658 | -1.777 | -1.966 | -2.12 | - | -2.329 | - | - |
| Operating Margin | -22,155.82% | -3,250.29% | -3,204.11% | -3,379.9% | -949.29% | - | -1,854.28% | - | - |
| Earnings before Tax (EBT) 1 | -1.105 | -1.642 | -1.777 | -1.965 | -2.112 | - | -2.329 | - | -4.961 |
| Net income 1 | -1.105 | -1.642 | -1.777 | -1.965 | -2.112 | -2.312 | -2.329 | -2.894 | -4.961 |
| Net margin | -22,198.19% | -3,219.86% | -3,203.68% | -3,378.77% | -945.71% | - | -1,854.28% | - | -1,417.43% |
| EPS 2 | -0.1300 | -0.1700 | -0.1900 | -0.2000 | -0.2100 | -0.2300 | -0.2100 | -0.2500 | -0.3200 |
| Dividend per Share | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/15/21 | 2/10/22 | 6/24/22 | 8/11/22 | 11/10/22 | 2/9/23 | 6/29/23 | 8/10/23 | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - |
| Net Cash position | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - |
| Capex | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - |
| Announcement Date | 6/29/21 | 6/24/22 | 6/29/23 | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.8197
USD
Average target price
5
USD
Spread / Average Target
+509.98%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -22.67% | 13.75M | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.36% | 26.25B | |
| +2.07% | 26.48B | |
| +12.96% | 24.62B |
- Stock Market
- Equities
- PETV Stock
- Financials PetVivo Holdings, Inc.
